ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Obama Signs Spending Bill for FY09

March 13, 2009

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

UICC Fellowship Program Announced

January 2, 1981

St. Jude Begins $100 Million Expansion Program

December 4, 1987

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979